Terrible? Why do you (and a % of others here ) consider it 'terrible'?
Is it because you had expected an overnight cure ?
Please dont get me wrong, Im not being critical. Im trying to put this into a logical perspective. Clinical trials are progressive.
With that frame of mind, those results provided to us from Replicel were actually great results.
On April 30th ,They had recently shown some great scientific head-way...
"RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise"
(later on in the story)
"In parallel to the tendon project, RepliCel continues to develop its cellular treatment for androgenetic alopecia (pattern baldness) named RepliCel Hair-01 (RCH-01). For the past few months RepliCel has been working with regulators to assemble a formal clinical trial application for submission to the Paul-Ehrlich-Institut (PEI), the German competent authority for human clinical trials involving cell therapy. In conjunction, the Company will make a submission to the responsible Ethics Committees. The trial is designed to demonstrate the efficacy and safety of injections of RCH-01 in approximately 120 male participants and will also provide insight into the optimal treatment regimen for hair growth."
Replicel is a great company doing many great things. Hang in there.
Is it because you had expected an overnight cure ?
Please dont get me wrong, Im not being critical. Im trying to put this into a logical perspective. Clinical trials are progressive.
With that frame of mind, those results provided to us from Replicel were actually great results.
On April 30th ,They had recently shown some great scientific head-way...
"RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise"
(later on in the story)
"In parallel to the tendon project, RepliCel continues to develop its cellular treatment for androgenetic alopecia (pattern baldness) named RepliCel Hair-01 (RCH-01). For the past few months RepliCel has been working with regulators to assemble a formal clinical trial application for submission to the Paul-Ehrlich-Institut (PEI), the German competent authority for human clinical trials involving cell therapy. In conjunction, the Company will make a submission to the responsible Ethics Committees. The trial is designed to demonstrate the efficacy and safety of injections of RCH-01 in approximately 120 male participants and will also provide insight into the optimal treatment regimen for hair growth."
Replicel is a great company doing many great things. Hang in there.
Comment